{"count": 5, "results": [{"_id": "12899584", "pmid": 12899584, "title": "Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial.", "journal": "Ann Intern Med", "authors": ["Devereux RB", "Dahlöf B", "Kjeldsen SE", "Julius S", "Aurup P", "Beevers G", "Edelman JM", "de Faire U", "Fyhrquist F", "Helle Berg S", "Ibsen H", "Kristianson K", "Lederballe-Pedersen O", "Lindholm LH", "Nieminen MS", "Omvik P", "Oparil S", "Snapinn S", "Wedel H", "LIFE Study Group"], "date": "2003-08-05T00:00:00Z", "doi": "10.7326/0003-4819-139-3-200308050-00006", "meta_date_publication": "2003 Aug 5", "meta_volume": "139", "meta_issue": "3", "meta_pages": "169-77", "score": 50061.496, "text_hl": "Effects of @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ or @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@ without clinically evident @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@vascular disease@@@: a substudy of the LIFE randomized trial.", "citations": {"NLM": "Devereux RB, Dahlöf B, Kjeldsen SE, Julius S, Aurup P, Beevers G, Edelman JM, de Faire U, Fyhrquist F, Helle Berg S, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Snapinn S, Wedel H, LIFE Study Group. Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial. Ann Intern Med. 2003 Aug 5;139(3):169-77. PMID: 12899584", "BibTeX": "@article{12899584, title={Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial.}, author={Devereux RB and Dahlöf B and Kjeldsen SE and Julius S and Aurup P and Beevers G and Edelman JM and de Faire U and Fyhrquist F and Helle Berg S and Ibsen H and Kristianson K and Lederballe-Pedersen O and Lindholm LH and Nieminen MS and Omvik P and Oparil S and Snapinn S and Wedel H and LIFE Study Group}, journal={Ann Intern Med}, volume={139}, number={3}, pages={169-77}}"}}, {"_id": "6627289", "pmid": 6627289, "title": "Effect of chronic atenolol therapy on the cardiovascular response to handgrip in hypertensive patients.", "journal": "Clin Ther", "authors": ["Orlandi C", "Fogari R"], "date": "1983-01-01T00:00:00Z", "meta_date_publication": "1983", "meta_volume": "5", "meta_issue": "6", "meta_pages": "632-7", "score": 50059.023, "text_hl": "The treatment did not prevent or attenuate the rise in heart rate with grip, but it partially inhibited the pressor response to handgrip. Chronic @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ therapy may reduce the risk of @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@vascular disease@@@ by decreasing blood pressure and its response to isometric exercise. ", "citations": {"NLM": "Orlandi C, Fogari R. Effect of chronic atenolol therapy on the cardiovascular response to handgrip in hypertensive patients. Clin Ther. 1983;5(6):632-7. PMID: 6627289", "BibTeX": "@article{6627289, title={Effect of chronic atenolol therapy on the cardiovascular response to handgrip in hypertensive patients.}, author={Orlandi C and Fogari R}, journal={Clin Ther}, volume={5}, number={6}, pages={632-7}}"}}, {"_id": "26811165", "pmid": 26811165, "pmcid": "PMC4859395", "title": "Comprehensive Assessment of Coronary Plaque Progression With Advanced Intravascular Imaging, Physiological Measures, and Wall Shear Stress: A Pilot Double-Blinded Randomized Controlled Clinical Trial of Nebivolol Versus Atenolol in Nonobstructive Coronary Artery Disease", "journal": "J Am Heart Assoc", "authors": ["Hung OY", "Molony D", "Corban MT", "Rasoul-Arzrumly E", "Maynard C", "Eshtehardi P", "Dhawan S", "Timmins LH", "Piccinelli M", "Ahn SG", "Gogas BD", "McDaniel MC", "Quyyumi AA", "Giddens DP", "Samady H"], "date": "2016-01-25T00:00:00Z", "doi": "10.1161/JAHA.115.002764", "meta_date_publication": "2016 Jan 25", "meta_volume": "5", "meta_issue": "1", "meta_pages": "", "score": 50057.367, "text_hl": "We hypothesized that @CHEMICAL_Nebivolol @CHEMICAL_MESH:D000068577 @@@nebivolol@@@, a beta-blocker with @CHEMICAL_Nitric_Oxide @CHEMICAL_MESH:D009569 @@@nitric oxide@@@-mediated activity, compared with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, a beta-blocker without such activity, would decrease oxidative stress and improve the effects of @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@endothelial dysfunction@@@ and wall shear stress (WSS), thereby reducing @DISEASE_Atherosclerosis @DISEASE_MESH:D050197 @@@atherosclerosis@@@ progression and vulnerability in @SPECIES_9606 @@@patients@@@ with nonobstructive @DISEASE_Coronary_Artery_Disease @DISEASE_MESH:D003324 @@@coronary artery disease@@@.", "citations": {"NLM": "Hung OY, Molony D, Corban MT, Rasoul-Arzrumly E, Maynard C, Eshtehardi P, Dhawan S, Timmins LH, Piccinelli M, Ahn SG, Gogas BD, McDaniel MC, Quyyumi AA, Giddens DP, Samady H. Comprehensive Assessment of Coronary Plaque Progression With Advanced Intravascular Imaging, Physiological Measures, and Wall Shear Stress: A Pilot Double-Blinded Randomized Controlled Clinical Trial of Nebivolol Versus Atenolol in Nonobstructive Coronary Artery Disease J Am Heart Assoc. 2016 Jan 25;5(1):. PMID: 26811165", "BibTeX": "@article{26811165, title={Comprehensive Assessment of Coronary Plaque Progression With Advanced Intravascular Imaging, Physiological Measures, and Wall Shear Stress: A Pilot Double-Blinded Randomized Controlled Clinical Trial of Nebivolol Versus Atenolol in Nonobstructive Coronary Artery Disease}, author={Hung OY and Molony D and Corban MT and Rasoul-Arzrumly E and Maynard C and Eshtehardi P and Dhawan S and Timmins LH and Piccinelli M and Ahn SG and Gogas BD and McDaniel MC and Quyyumi AA and Giddens DP and Samady H}, journal={J Am Heart Assoc}, volume={5}, number={1}}"}}, {"_id": "16187009", "pmid": 16187009, "title": "Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease.", "journal": "Cardiovasc Drugs Ther", "authors": ["Lekakis JP", "Protogerou A", "Papamichael C", "Vamvakou G", "Ikonomidis I", "Fici F", "Mavrikakis M"], "date": "2005-08-01T00:00:00Z", "doi": "10.1007/s10557-005-3117-9", "meta_date_publication": "2005 Aug", "meta_volume": "19", "meta_issue": "4", "meta_pages": "277-81", "score": 50054.805, "text_hl": "No significant differences were observed between the two groups at baseline in FMD. In the @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ group FMD remained unchanged at the end of the 4-week treatment, but in @SPECIES_9606 @@@patients@@@ treated with @CHEMICAL_Nebivolol @CHEMICAL_MESH:D000068577 @@@nebivolol@@@ FMD showed a significant increase by the end of the treatment period (3.9 +/- 2.7% vs. 5.6 +/- 2.9%, p = 0.047) leading to a significantly higher value compared to @SPECIES_9606 @@@patients@@@ treated with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ (5.6 +/- 2.9% vs. 3.4 +/- 3.2%, p = 0.041).Beta(1) blockade by @CHEMICAL_Nebivolol @CHEMICAL_MESH:D000068577 @@@nebivolol@@@ but not @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ improves @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@endothelial dysfunction@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Coronary_Artery_Disease @DISEASE_MESH:D003324 @@@CAD@@@, an effect that might further reduce the risk for cardiovascular events in @SPECIES_9606 @@@patients@@@ with @DISEASE_Coronary_Artery_Disease @DISEASE_MESH:D003324 @@@CAD@@@.", "citations": {"NLM": "Lekakis JP, Protogerou A, Papamichael C, Vamvakou G, Ikonomidis I, Fici F, Mavrikakis M. Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease. Cardiovasc Drugs Ther. 2005 Aug;19(4):277-81. PMID: 16187009", "BibTeX": "@article{16187009, title={Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease.}, author={Lekakis JP and Protogerou A and Papamichael C and Vamvakou G and Ikonomidis I and Fici F and Mavrikakis M}, journal={Cardiovasc Drugs Ther}, volume={19}, number={4}, pages={277-81}}"}}, {"_id": "3937284", "pmid": 3937284, "title": "Inhibition of platelet aggregation in whole blood by adrenoceptor antagonists.", "journal": "Thromb Res", "authors": ["Greer IA", "Walker JJ", "Calder AA", "Forbes CD"], "date": "1985-12-01T00:00:00Z", "doi": "10.1016/0049-3848(85)90301-9", "meta_date_publication": "1985 Dec 1", "meta_volume": "40", "meta_issue": "5", "meta_pages": "631-43", "score": 50038.86, "text_hl": "The anti-platelet effect of these drugs may be of value in the treatment of @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@vascular disease@@@.", "citations": {"NLM": "Greer IA, Walker JJ, Calder AA, Forbes CD. Inhibition of platelet aggregation in whole blood by adrenoceptor antagonists. Thromb Res. 1985 Dec 1;40(5):631-43. PMID: 3937284", "BibTeX": "@article{3937284, title={Inhibition of platelet aggregation in whole blood by adrenoceptor antagonists.}, author={Greer IA and Walker JJ and Calder AA and Forbes CD}, journal={Thromb Res}, volume={40}, number={5}, pages={631-43}}"}}]}